Skip to main content
. 2021 Nov 22;2021(11):CD004407. doi: 10.1002/14651858.CD004407.pub5

Comparison 17. Safety: hay fever, rhinoconjunctivitis, hypersensitivity/allergy.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
17.1 Cohort study ‐ rhinoconjunctivitis 1   Odds Ratio (IV, Fixed, 95% CI) 0.64 [0.19, 2.11]
17.2 Cohort study ‐ hypersensitivity/allergy 1   Odds Ratio (IV, Fixed, 95% CI) 0.63 [0.14, 2.77]
17.3 Case‐control ‐ hay fever 2   Odds Ratio (IV, Random, 95% CI) 1.16 [0.92, 1.45]